170
Views
36
CrossRef citations to date
0
Altmetric
Research Article

A Spectrum of Mutations in SH2D1A That Causes X-linked Lymphoproliferative Disease and Other Epstein-Barr Virus-associated Illnesses

, , , , , , , , , & show all
Pages 1189-1201 | Published online: 01 Jul 2009

  • Purtilo, U.T.Cassel, C.K., Yang, JP. and Harper, R. (1975) "X-Iinked recessive progressive combined variable immunodeficiency (Duncan's disease)". Lancet 7913, 935-940.
  • Wu, C. Nguyen, K.B. Pien, GC. Wang, N. Gullo. C. Howie, D. Sosa. M.R. Edwards. M.J., Borrow, P., Satoskar, A.R., Sharpe, A.H., Biron, C.A. and Terburst C. (2001) "Sap controls T cell responses lo virus and terminal differentiation of TH2 cells", Nature immunology 2. 382-384.
  • Seemayer, T.A. Gross, T.G., Egeler, R.M., Pirruccello, S.J., Davis, J.R. Kelly, CM., Okano, M. Lanyi, A. and Sumegi, J. (1995) "X-linked lymphoproliferative disease: twenty-five years after the discovery". Pediatric Research 38, 471-478.
  • Brandau, O. Schuster, V. Weiss, M. Fink, F.M., Kreezy, A. Kricdrich, W. Strahm, B. Nieraeyer, C. Belohradsky, B.H. and Meindl, A. (1999) "Epstein-Barr virus-negative boys with nonHodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XIJ5)". Human Molecular Genetics 8, 2407-2413.
  • Sumegi, J. Huang, D., Lanyi, A. Uavis, JR. Seemayer, T.A. Maeda, A, Klein, G. Seri, M., Wakiguchi, H. Purtilo, DT and Gross, T.G. (2000) "Correlation of mutations of the SH2DIA gene and Epstetn-Barr virus infection with clinical phenolype and outcome in X-linked proliferativc disease", Blood 96, 3118-3125.
  • Coficy, A.J. Brooksbank, R.A. Brandau, O. Achatz, H. Howell, G.R. Bye'Anlhofly, J.M. Cahn, P. Durham, J. Heath, P. Pavin, R. Wilkinson, J. liversha, M., Huckle, E. Shaw Smith, C.J. Dunham, A. Rhodes, S. Porta, G., Yin, L., Seraftni, P. SyIIa, B. ZoIIo, M., Franco, B. Bolino, A. Sen, M., I-anyi, A. Davis, J.R. Webster, D., Harris, A. Unoir, G., de St Basile, G. Schuster, V. Weiss, G., Oohasai, T. Faessler, R. Murken, J. Sumegi, J. Surnegi, J. Romeo, G. Vaudin, M. Ross, M.T., Meindl, A. and Bentley, D.R. (1998) "The aberrant host response to EBV infection in X-linked Lymphoproliferative disease results from mutations in a novel SH2-domain encoding gene, SH2DI A", Sature Genetics 20, 129-135.
  • Nichols, K.E. Harkin, O.P. Levit, S. Krainer, M. Kolquisl, K.A. Genovese, C., Bernard, A., Ferguson, M. Zuo, L. Snyder, E., Buckler, A.J. Wise, C. Ashley, J. Loveu, M. Valentine, M.B. Look, AT. Gerald, W. Housman, D.E. and Haber, D.A. 11998) "Inactivating mutations in an SH2 domain-encoding gene in X-linkcd lymphoproliferative syndrome", rmteedings rif the National Academy f Science USA 95. 13765-13770.
  • Saves, J., Wu, C. Monra, M., Wang, N. Zhang, X. Allen, U. Van Schaik, S. Notarangelo, L. Cicha, R. Roncarolo, M.G. Oettgen, H., de Vries, J.E. Aversa, G. and Terhorst, C. (1998) "The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM". Nature 395, 462-469.
  • Wu, C. Sayos, !. Wang, N. Howic, D. Coyle, A. and Tcrhorst, C (2000) "Genomic organization and characterization of mouse SH2DIA. the gene that is altered in X-Iinked lymphoproliferative disease", lmmunogenetics 51, 805-815.
  • Morra, M. Siniarro-Grande, M. Siau-In Chen, A., l.anyi, A. Silander, O. Sumegi, J., Eck, M. Pawson, T. Li, SC. and Terhorst, C. (2001) "Misseose mutations thai affect non-phospho-tyrosine interactions and stahility of the SAP/SH2D1A SH2-doniain in X-linked lymphoproliferative disease patients", Journal of Biological Chemistry 276, 36809-36816.
  • Nagy, N. Cerboni, C., Mattsson, K. Macda, A. Gogolak, P. Sumegi, J. !.anyi, A, Szckely, 1.. Carbone, E., Klein, G. and Klein, C. (2000) "SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines", lnternatinal Journal of Cancer 88. 439-447.
  • Thompson, A.D. Braun, B.S. Arvand, A. Stewart, S.D., May, W.A. Chen, E. Korenberg, J. and Denny, C. (1996) "Eat-2 is a novel S112 domain containing protein thai is up regulated by Swing's sarcoma F.WS/FL11 fusion gene". Uncogene 13. 2649-2658.
  • Morra, M.Lu.J,. Poy, F. Martin, M. Sayos, J. Calpe, S. GuIIo,C. Howic, D, Rietdijtc, S., Thompson, A. Coyle, A.J. Denny, C. Yaffe, M.Y., Engel, P., Eck, M.J. ami Terhorst, C (2001 ) "Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in unmunocytes", EMBO Journal 20. 1-13.
  • Poy, K, Yaffe, B. Sayos, J. Saxena, K. Morra, M., Suiriegi, J. Cantley, LC. Terhorst, C and Eck, M.J. (1999) "Crystal structures of the Xl.P protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition". Molecular Cellulur 4, 555-562.
  • Li, S.C. Gish, G. Yang, D. Coffcy, A.J. Fonnan-Kay,. I.D. Ernberg, I. Kay, L.E. and Pawson, T. (1995) "Novel mode of ligand binding by the SH2 domain of lhe human XLP disease gene product SAP/SH2DIA", Current Biology 9. 1355-1362.
  • Seed, B. and Aruffo, A. (1987) "Molecular cloning of the CD2 antigen, the T-ccll crythrocyte receptor, by a rapid immunoselection procedure". Proceedings of the National Academy of Science, USA 84. 3365.
  • Staunton, D.E. and Thorley-Lawson, D.A. (1987) "Molecular cloning of the lymphocyte activation marker Blast-I". EMBO Journal 6, 3695-3699.
  • Seed, B. (1987) "An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2". Nature 329. 840-842.
  • Cocks, BG. Change, C.-CJ., Carballido, JM. Yssel, H. de Vrics, J.E. and Aversa, G. (1995) "A novel receptor involved in T-cell activation". Nature 376. 260-263.
  • De Ia Fuente, M.A. Pizcueta, P. Nadal, M. Bosch, J. and Engel, P. (1997) "CD84 leukocyte antigen is a new member of the Ig superfamily". Blood 90, 2398-2405.
  • Sandrin, M.S. Gumley, TP, Henning, M.M., Vaughan, H.A. Gonez, L.J., Trapani, J.A. and McKenzie, I.K (1992) "Isolation and characterization of cDNA clones for mouse Ly-9", Journal of Immunology 149, 1636-1641.
  • Valiante, N.M. and Trinchieri, G. (1993) "Identification of a novel signal lransduction surface molecule on human cytoioxic lymphocytes". Journal of Experimental Medicine 178. 1397-1406.
  • Gami-Wagncr, B.A. Purohii, A., Matthew, P.A. Bennett, M. and Kumar, V. (1993) "A novel function-associated molecule related Io non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells". Journal of Immunology 151, 60 70.
  • Kingsbury, G.A., Feeney, L.A. Nong, Y, Calandra, S.A. Murphy, CJ. Corcoran, J.M., Wang, Y. Prabhu Das, M.R. Busfield, S.J. Fraser, C.C. and Villeval, J.L (2001) "Cloning, expression, and function of blame, a novel member of the cd2 family". Journal of Immunology 166. 5675-5680.
  • Boles, K.S. and Matthew, P.A. (2001) "Molecular cloning of CSI. a novel human natural killer cell receptor belonging to the CD2 subset of the immunoglobulin superfamily". lmmunogtnetics 52. 302-307.
  • Williams, A.F. and Barclay, A.N. (1998) "The immunoglobulin liupcrfamily-domains (or cell surface recognition". Annual Review* nf Immunlgy 6, 381-405.
  • Wong, Y.W. Williams, A.F. Kingsmore, S.F. and Seidin, M.F. (1990) "Structure, expression, and genetic linkage of lhe mouse BCMl (OX45 or Blasl-1) antigen. Evidence for genetic duplication giving rise to the BCMl region on mouse chromosome 1 and the CD2/LFA3 region un mouse chromosome 3", Journal of Experimental Medicine 171, 2115-2130.
  • Davis, SJ. Ikemizu, S. Wild, M.K. and van der Menve, P.A. (1998) "CD2 and the nature of protein interactions mediating cell-cell recognition", Immunology Reviews 163, 217 - 236.
  • Brown, M.H. Boles, K., van der Merwe, P.A. Kumar, V. Mathew, P.A. and Barclay, A.N, (1998) "2B4. the natural killer and T tell immunogolobulin superfamily surface protein, is a ligand for CD48". Journal of Experimental Medicine 188, 2083-2190.
  • Tangye, S.O. Phillips, J.H. and Unier, L.L. (2000) "The CD2-subset of the Ig superfaniuy of cell surface molecules: receptor-Iigand pairs expressed by NK cells and other immune cells". Seminars in Immunology 12. 149.
  • Tangye, S.G., Lazctic, S. Woollatt, E., Sutherland, G.R. l.anier, LL. and Phillips, J.H. (1999) "Human 2B4. an activating natural killer cell receptor, recruits the protein tyrosiue phnsphatase SHP-2 and the adaptor signaling protein SAP". Journal of Immunology 162.6981-6985.
  • Sayos, J., Martin, M., Chen, A. Simarro, M. Howie, D. Morra, M. Engel, P. and Terhorst, C. (2001) "Cell surface receptors Ly-9 and CDM recruit the X-linked lymphoproliferative gene product SAP". Blood 97. 3867 3874.
  • Shlapatska, L.M. Mikhalap, S.V. Berdova, A.C. Zelensky, O.M. Yun, TJ. Nichols, K.E., Clark, F.A. and Sidorenko, S.R (2001) "CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phusphata.se is regulated by the adaptor protein SH2DIA". Journal of Immunology 166. 5480 5487.
  • Aversa, G. Chang, C.C. Carballido, J.M. Cocks, B.C. and de Vries, J.E. (1997) "Engagement of the signalling activation molecule (Sl.AM) on activated T cells result in -2 independent, cyclosporin A sensitive T cell proliferation and IFN--y production". Journal of Immunology 158, 4036.
  • Mikhalap, S.V., Shlapatska, L.M. Berdova, A.C5. Law, C.L. Clark, E.A. and Sidorenko, S.P. (1999) "CDwISO associates with srchomology 2 containing inositol phosphatasc and modulates CD95-mediated apoptosis", Journal of Immitnolagv 162, 5719 5727.
  • Freeman, Jr., R.M. Plutzky, J. and Neel, B.C. (1992) "Identification of human sic homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosoprula corkscrew". Proceedings of the National Academy of Science. USA 89, 11239- 11243.
  • Leehleider, R.J., Sugimoto, S, Bennett, A.M. Kashishian, A.S. Cooper, J.A. Shoelson, S.E. Walsh, C.T and Necl, B.G (1993) "Activation of the SH2-containing phosphotyrosine phosphatase. SH-PTP2 by its binding site, phosphotyrosine 1009, on the human PDGF-R". Journal of Biological Chemistry 268, 21478 21480.
  • Pluskey, S. Waudlass, TJ. Walsh, C.T. and Shoelson, S.E. (1995) "Potent stimulation of SH-PTP2 phospnatase activity by simultaneous occupancy of both SH2 domains". Journal of Biological Chemistry 270. 2897-2900.
  • Eck, M. Pluskey, S., Trab, T. Harrison, S.C. and Shoelson, S.E. (1996) "Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphalase SH-PTP2", Nature 379. 277-280.
  • Wu, C, Sayos, J. Wang, N. Howie, D. Coyle, A. and Terhorst, C. (2000) "Genomic organisation and characterization of mouse SAP. the gene that is altered in X-linked lymphoproliferative disease". Immunogenetics 51, 805-815.
  • Lamkin, T.D., Walk, S.F. Liu, L. Damen, J.E., Kryslal, G. and Ravichandran, K.S. (1997) "She interaction with Src homology 2 domain containing inositol phosphaia.se (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosincs on SHIP", Journal of Biological Chemistry 272. 10396 10401.
  • Gami-Wagner, B.A. Purohil, A. Mathew, P.A., Bennetl, M. and Kumar, V. (1993) "A novel function-associated molecule related to non-MHC-restricted cytoloxicity mediated by activated natural killer cells and T cells". Journal of Immunology 151. 60 70.
  • Brown, MH. Boles, K., van der Merwe, P.A. Kumar, V, Mathew, P.A. aud Barclay, A.N. (1998) "2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand forCD48". Journal of Experimental Medicine 188. 2083 2090.
  • Latchman, Y., McKay, PF. and Reiser, II. (1998) "Identification of the 2B4 molecule as a counter-receptor for CD48". Journal of Immunology 161. 5809-5812.
  • Valiame, N.M. and Trinchieri, G. (1993) "Identification of a novel signal lransductioD surface molecule on human cylotoxic lymphocytes". Journal of Experimental Medicine 178. 1397.
  • Nakajima, H., Cella, M. I-angen, H., Friedlein, A. and Colonna, M. (1999) "Activating interacuons in human NK cell recognition: the role of 2B4-CD48", Eurpean Journal Immunlgy 29.1676-1683.
  • Kubin, M.Z., Parshley, D.L. Din, W. Waugh, J.Y. Davis-Smilh, T. Smith, C.A. Macduff, B.M. Armilage, R.J., Chin, W., Cassiarm, L. Borges, L., Petersen, M. Trinchieri, G. and Goodwin, R.G. (1999) "Molecular cloning and biological characterization of NK cell activation-inducting tigand. a counlerslruciurc for CD48", European Journal of Immunology 29, 3466-3477.
  • Tangye, S.G. Phillips, J.H.' Lanier, L.L. and Nichols, K.E. (2000) "Functional requirement for SAP in 2B4-mediaied activation of human natural kilter cells as revealed by the X-linked lyrnphoproliferative syndrome". Journal of Immimoloxv 165, 2932-2936.
  • Benoit, L.. Wang, X. Pabst, H.F. Dutz, J. and Tan, R. (2000) "Defective NK cell activation in X-linked lymphoproliferative disease". Journal of Immunology 165, 3549-3553
  • Paroltni, S. Bottino, C. Falco, M. Augugliaro, R. Giliam, S. Franceschini, R. Ochs, H.D. Wolf, H. Bonnefoy, J.Y. Biassoni, R. Morelta, L. Notarangelo, L.D. and Moreua, A. (2000) "X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstcin Barr virus-infected cells". Journal of Experimental Medicine 192. 3.37-346.
  • Schatzle, J.D. Sheu, S. Stepp, S.F., Mathew, P.A. Bennett, M. and Kumar, V. (1999) "Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4". Proceedings of the AOuV)HO/ Academy of Science. USA 96. 3870-3875.
  • Wisniewski, D. Strife, A. Wojciechowicz, D. Lambck, C. and Clarkson, B. (1994) "A 62 kilodalion tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogcnous leukemia enriched lineage negative blast populations". Leukemia 8, 688-693.
  • Carpino, N. Wisniewski, D., Strife, A. Marshak, D. Kobayashi, R. Stillmaa, B. and Clarkson, B. (1997) "p62(dok): a conslitulively tyrosine-phosphorylatcd GAP-associated protein in chronic myelogenous leukemia progenitor cells". Cellular Inununolgy 88, 197-204.
  • Di Cristofano, A., Carpino, N., Dunant, N. Friedland, G. Kobayashi, R., Strife, A., Wisniewski, D. Clarkson, B. Pandolfi, P.P. and Resh, M.D. (1998) "Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins". Journal of Biolgic Chemistry 273, 4827-4830
  • Lemay, S. Davidson, D., Latour, S. and Veillelte, A. (2000) "Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling". Molecular and Cellular Biologv 20. 2743 2754.
  • Yamanashi, Y. Tamura, T. Kanamori, T. Yamane, H. Nariuchi, H. Yamamoto, T. and Baltimore, D. (2000) "Role of the rasGAPassociated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling", Genes and Development 14, 11 -16.
  • Sylla, B.S. Murphy, K., Cahir-McFarland, F.. Lane, W.S. Mosialos, G. and Kieff, E. (2000) "The X-linked lymphoproliferative syndrome gene product SH2DIA associates with p62dok (Dokl) and activates NF-kappa B", Proceedings of the National Academy of Science 97. 7470-7475.
  • Songyang, 'Z.. Yamanashi, Y., Liu, D. and Baltimore, D. (2001) "Domain-dependent function of the rasGAP-binding protein p62Dok in cell signaling". Journal of Biological Chemistry 276, 2459-2465.
  • Sylla, B.S., Waag, O., Hayor, D. Lathrop, G.M. and Lenoir, d.M. (1989) "Multipoint linkage mapping of the Xq25-q26 region in a family affected by the X-linked lymphoproliferative syndrome". Clinical of Genetics 36. 459 -462.
  • Bolino, A. Yinh Sen, M., Casano, R. Ciuti, R., Coffey, A. Brooksbank, R. Howell, G, Gcntley, D. Davis, J.R. Lanyi, A. Huang, D., Strak, M. Creaven, M., Bjorkhang, J. and Heitzmann, F. (1998) "A new candidate region for the positional cloning of the XLP gene", European Journal of Human Genetics 6. 509-517.
  • Yin, L. Ferrand, V, Lavoue, M.J. Ilayoz, D. Philippe, N, Souillct, G. Seri,M. Giacchino, R. Caslapioia, E. Hodgson, S. Sylla, B.S. and Romeo, G. (1999) "SH2D1A mutation analysis foi diagnosis ofXLP in typical and atypical patients". Human Genetics 105. 501-505.
  • Strahm, B. Ritlwcilcr, K. Dufiner, U. Brandau, O., OrlowskaVoIk, M. Karajannis, M.A. Siadt, Uz. Tiemann, M. Reiter, A. Brandis, M., Meindl, A. and Viemeyer, C.M (2000) "Recurrent B-cell non-Hodgkin's lyinphooiii in [wo brothers with X-linkeil lymphoproliferative disease without evidence for Epstein-Barr virus infection". British Jvumal of Haematology 108. 377 382.
  • Lappalaincn, I. Guiana, S. Franceschini, R. Franccschini, R. Bonnefoy, J.Y. Duckett, C. Notarangclo, L.D. and Vihinen, M. (2000) "Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease". Biochemical and Biophysical Research Communication 269, 124-130
  • Schuster, V. and Kreth, H.W. (2000) "X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein". Immunology Rei'iews 178. 21-28.
  • Arico, M. Imashuku, S. Clementi, R. Hibi, S. Teraruura, T. Danesino, C.'., Haber, D.A. and Nichols, K.h. (2001) "Hemophagocytic lympbohisticytsisMS due to germline mutations in SH2D1A. the X-linked lymphoproliferative disease gene". Blood 97. 1131-1133.
  • Dutz, J.P., Benoit, 1.. Wang, X. Demetrick, D.J. Juuker, A. deSa, D. and Tan, R. (2001) "Lymphocylic vasculities Ln X-linked lymphoproliferative disease". Blood 97. 95-100.
  • Honda, K., Kanegane, H. Eguchi, M, Kimura, H. Merishima, T. Musaki, D. Tosato, G. Miyawaki, T. and lshi, E. (2000) "Large deletion of the X-linked lymphoproliferative disease gene detected hy fluorescence in situ hybridization". American Journal of Hematology 64, 128-132.
  • Gilmour, K.C. Cranston, T. Jones, A., Davies, E.G. Goldblatl, D. Thrasher, A. Kinnon, C. Nichols, K.t. and Gaspar, H.B. (2000) "Diagnosis of X-linked Iymphoprol iferalive disease by analysis of SLAM-associated protein expression". European Journal nf Immunology 30, 1691-1697.
  • Maregere, LE. and Pawson, T. (1992) "Identification of residues in GTPase activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62". Journal of Biological Chemistry 267. 22779 -22786.
  • Mayer, B.F. Jackson, P.K. Van Ellen, R.A. and Baltimore, D. (1992) "Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vilm and transforming activity in vivo". Molecular and Cellular Biology 12. 609 618.
  • Conley, M.E. Mathias, D., Treadaway, J. Minegishi, Y. and Rohrer, J. (1998) "Mutations in btk in patients with presumed X-linked agammaglobulinenia". American Journal of Human Genetics 62. 1034-1043.
  • Morra, M. Silander, O. Calpe-Flores, S., Choi, M. Oeugen, H. Myers, L. Hlzioni, A. Buckley, R. and Terhorst, C. (2001) "Alterations of the X-linked lymphoproliferative disease gene SAP/SH2DIA in the Common Variable Immunodeficiency syndrome". Blood 98. 1321 -1325.
  • Sumazaki, R. Kanegane, H., Osaki, M. Fukushima, T. Tsuchida, M.Y, Matsukura, H., Shinozaki, K. Kimura, H. Matsui, A. and Miyawaki, T. (2001) "SH2D1A mutations in Japanese males with severe F.pstein Barr virus-associated illnesses". Blood 98. 1268-1270.
  • Czar, M.J. Kersh, E.N. Mijares, L.A. Lamer, G. Lewis, J. Yap, G. Chen, A., Sher, A., Ducken, C.S., Ahmed, R. and Schwanzberg, P.I. (2001 ) "Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative discnse gene SH2D1A/DSHP/SAP". Pmctf dings of the Nalional Acadenn of Science. USA 98. 7449-7454.
  • Satterthwait, A.B. Rawlings, D.F. and Wine, O.N. (1998) "DSHP: A "power bai" for sustained immune responses". Proceedings of the National Academy of Science 95. 13355 - 13357.
  • Howie, D. Sayos, J., TerhorsU C. and Morra, M. (2000) "The gene defective in X-linked lymphoproliferalive disease controls T cells dependent immune surveillance againsl Epslein-Barr virus". Current Opinion in Immunology 12. 474-478.
  • Sullivan, J.F. (1999) "The abnormal gene in X-linked lymphoproliferative syndrome". Current Opinion of Immunology 11, 431-434.
  • Latour, S. Gish, G, Helgason, C.D., Humphries, R.K. Pawson, T. and Veillette, A. (2001) "Regulation of SLAM-mediated signal transduclion by SAP, the X-linked lymphoproliferalive gene producl". Nature Immunology 2, 681 690.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.